Foresite Capital Management IV, LLC

Foresite Capital Management IV, LLC holds a significant stake as a 10% owner in Kinnate Biopharma Inc. This profile details their trading activities, highlighted by a recent SEC Form 4 filing on April 5, 2024, reflecting a transaction valued at approximately $1.3 million. The disclosed activity is concentrated in Kinnate Biopharma Inc. (ticker: KNTE), showcasing their involvement in the biotechnology sector.